Nu Skin Enterprises (NYSE:NUS) issued an update on its second quarter 2019 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $0.82-0.84 for the period, compared to the Thomson Reuters consensus estimate of $0.94. The company issued revenue guidance of $622-623 million, compared to the consensus revenue estimate of $673.95 million.Nu Skin Enterprises also updated its FY 2019 guidance to $3.20-3.35 EPS.
A number of equities analysts have commented on the stock. Deutsche Bank downgraded shares of Hilton Hotels from a buy rating to a hold rating and set a $92.60 target price on the stock. in a research note on Wednesday, May 1st. They noted that the move was a valuation call. ValuEngine upgraded shares of Valmont Industries from a sell rating to a hold rating in a research note on Friday. Zacks Investment Research downgraded shares of Inflarx from a buy rating to a hold rating in a research note on Friday, May 3rd. Bank of America dropped their target price on shares of Canopy Growth from $80.00 to $75.00 and set a buy rating on the stock in a research note on Wednesday, June 19th. Finally, Stifel Nicolaus set a $99.00 target price on shares of C.H. Robinson Worldwide and gave the stock a hold rating in a research note on Monday, March 25th. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the company’s stock. The company currently has an average rating of Hold and an average target price of $73.13.
Shares of NYSE NUS traded up $1.48 during midday trading on Tuesday, reaching $45.51. 409,975 shares of the company’s stock traded hands, compared to its average volume of 653,478. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.10 and a current ratio of 1.86. The stock’s 50 day moving average is $48.16. Nu Skin Enterprises has a one year low of $43.57 and a one year high of $88.68. The stock has a market cap of $2.48 billion, a P/E ratio of 12.93, a price-to-earnings-growth ratio of 1.03 and a beta of 0.74.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Further Reading: What is a trade deficit?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.